Skip to content

Hims & Hers Health HIMS Payments Of Debt Issuance Costs

Payments Of Debt Issuance Costs at other companies

Humana logo
HumanaHUM
IQVIA logo
IQVIAIQV

Other financials

Income statement

See full
Revenue$608.1M+3.8%
Gross profit$396.8M-7.9%
Operating income-$78.3M-235%
Net income-$92.1M-286%
EPS (diluted)-$0.40-300%

Balance sheet

See full
Cash & equivalents$222.3M-19.2%
Total debt$157.9M+149%
Total equity$446.2M-18.8%
Total assets$2.3B+154%

Cash flow

See full
Operating cash flow$89.4M-18.1%
CapEx$8.8M-19.9%
Free cash flow$80.5M-17.9%

Valuation

See full
Market cap$8.21B-27.9%
Enterprise value$8.15B-26.5%
P/S3.5×-2.9×

Profitability

See full
Gross margin71.7%-5.3pp
Operating margin-1.3%-7.5pp
Net margin-0.6%-9.8pp
FCF margin11.9%-5.8pp

Returns & leverage

See full
Return on equity-2.7%-39.4pp
Debt / equity0.4×+0.2×
Current ratio1.7×+0.1×

Where this comes from

Reported directly by Hims & Hers Health in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfDebtIssuanceCosts.

The official record: Hims & Hers Health’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Hims & Hers Health's payments of debt issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Hims & Hers Health's payments of debt issuance costs?
Hims & Hers Health (HIMS) reported payments of debt issuance costs of $0 in Q1 2026.
How has Hims & Hers Health's payments of debt issuance costs changed year-over-year?
Hims & Hers Health's payments of debt issuance costs decreased by 100.0% year-over-year, from $1.24M to $0.